Skip to main content

An adverse lipoprotein phenotype-hypertriglyceridaemic hyperapolipoprotein B-and the long-term risk of type 2 diabetes: a prospective, longitudinal, observational cohort study.

Publication ,  Journal Article
Pencina, KM; Pencina, MJ; Dufresne, L; Holmes, M; Thanassoulis, G; Sniderman, AD
Published in: Lancet Healthy Longev
May 2022

BACKGROUND: This study examines the risk of new-onset diabetes in patients with hypertriglyceridaemic hyperapolipoprotein B (high triglycerides, high apolipoprotein B [apoB], low LDL cholesterol to apoB ratio, and low HDL cholesterol). The aim was to establish whether this lipoprotein phenotype identified a substantial group at high risk of developing diabetes over the next 20 years. METHODS: In this prospective, longitudinal, observational cohort study, we used data from the Framingham Offspring cohort (recruited in Framingham, MA, USA). Participants were aged 40-69 years and free of diabetes and cardiovascular disease at a baseline examination done between April, 1987, and November, 1991, and were followed up until March, 2014. Cox proportional hazards regression with hierarchical adjustment for age and sex, waist circumference, and fasting blood glucose were used to model the relationship between each lipid marker and incident diabetes, as well as the relationship between hypertriglyceridaemic hyperapoB (defined as values greater than sample medians of triglycerides and apoB, and less than medians of HDL cholesterol and LDL cholesterol to apoB ratio) and incident diabetes. FINDINGS: Of 3446 individuals aged 40-69 years who completed baseline examination, 2515 participants were eligible and included in all analyses. During median 21·1 years (IQR 11·1-23·1) of follow-up, 402 (16·0%) individuals developed diabetes. Age (p=0·032), waist circumference (p<0·0001), fasting blood glucose (p<0·0001), and natural logarithm-transformed triglycerides (p<0·0001) were associated with new-onset diabetes, as were apoB (p=0·0016), LDL cholesterol to apoB ratio (p=0·0018), and HDL cholesterol (p=0·0016) when added to this model. The age and sex-adjusted incidence of diabetes in the hypertriglyceridaemic hyperapoB group was 32·4% (95% CI 27·8-37·7) versus 5·5% (3·5-8·6) in the optimal lipid phenotype group and 15·5% (13·5-17·7) in the mixed lipid phenotype group. The fully adjusted hazard ratio, including glucose and waist circumference, for individuals with hypertriglyceridaemic hyperapoB was 3·30 (95% CI 2·06-5·30; p=0·0008) and for mixed lipid phenotype was 2·17 (1·38-3·40; p<0·0001) compared with those with the optimal lipid phenotype. INTERPRETATION: Our findings suggest that individuals with hypertriglyceridaemic hyperapoB are at high risk of new-onset diabetes and might benefit from intensive measures to prevent diabetes. The association between this phenotype and incident diabetes is consistent with a pro-diabetic effect due to increased clearance of apoB particles from plasma, which could injure pancreatic islet cells. This mechanism might explain the increased risk of diabetes with statin therapy. FUNDING: Doggone Foundation.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Lancet Healthy Longev

DOI

EISSN

2666-7568

Publication Date

May 2022

Volume

3

Issue

5

Start / End Page

e339 / e346

Location

England

Related Subject Headings

  • Triglycerides
  • Prospective Studies
  • Phenotype
  • Lipoproteins
  • Humans
  • Diabetes Mellitus, Type 2
  • Cohort Studies
  • Cholesterol, LDL
  • Cholesterol, HDL
  • Blood Glucose
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pencina, K. M., Pencina, M. J., Dufresne, L., Holmes, M., Thanassoulis, G., & Sniderman, A. D. (2022). An adverse lipoprotein phenotype-hypertriglyceridaemic hyperapolipoprotein B-and the long-term risk of type 2 diabetes: a prospective, longitudinal, observational cohort study. Lancet Healthy Longev, 3(5), e339–e346. https://doi.org/10.1016/S2666-7568(22)00079-4
Pencina, Karol M., Michael J. Pencina, Line Dufresne, Michael Holmes, George Thanassoulis, and Allan D. Sniderman. “An adverse lipoprotein phenotype-hypertriglyceridaemic hyperapolipoprotein B-and the long-term risk of type 2 diabetes: a prospective, longitudinal, observational cohort study.Lancet Healthy Longev 3, no. 5 (May 2022): e339–46. https://doi.org/10.1016/S2666-7568(22)00079-4.
Pencina KM, Pencina MJ, Dufresne L, Holmes M, Thanassoulis G, Sniderman AD. An adverse lipoprotein phenotype-hypertriglyceridaemic hyperapolipoprotein B-and the long-term risk of type 2 diabetes: a prospective, longitudinal, observational cohort study. Lancet Healthy Longev. 2022 May;3(5):e339–46.
Pencina, Karol M., et al. “An adverse lipoprotein phenotype-hypertriglyceridaemic hyperapolipoprotein B-and the long-term risk of type 2 diabetes: a prospective, longitudinal, observational cohort study.Lancet Healthy Longev, vol. 3, no. 5, May 2022, pp. e339–46. Pubmed, doi:10.1016/S2666-7568(22)00079-4.
Pencina KM, Pencina MJ, Dufresne L, Holmes M, Thanassoulis G, Sniderman AD. An adverse lipoprotein phenotype-hypertriglyceridaemic hyperapolipoprotein B-and the long-term risk of type 2 diabetes: a prospective, longitudinal, observational cohort study. Lancet Healthy Longev. 2022 May;3(5):e339–e346.

Published In

Lancet Healthy Longev

DOI

EISSN

2666-7568

Publication Date

May 2022

Volume

3

Issue

5

Start / End Page

e339 / e346

Location

England

Related Subject Headings

  • Triglycerides
  • Prospective Studies
  • Phenotype
  • Lipoproteins
  • Humans
  • Diabetes Mellitus, Type 2
  • Cohort Studies
  • Cholesterol, LDL
  • Cholesterol, HDL
  • Blood Glucose